SCHEMBL28857883

SCHEMBL28857883

CC(OC(=O)OC(C)c1ccc2c(c1)C(=O)c1ccccc1C2=O)c1ccc2c(c1)C(=O)c1ccccc1C2=O

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ALDH1A1 P00352 6/20 0.49
▸ NPC1 O15118 6/20 0.49
▸ RAB9A P51151 5/20 0.49
▸ SMN1; SMN2 Q16637 4/20 0.49
▸ MEN1 O00255 4/20 0.49
▸ KMT2A Q03164 4/20 0.49
▸ MAPT P10636 3/20 0.49
▸ MAOA P21397 1/20 0.49
▸ TTR P02766 1/20 0.46
▸ ELANE P08246 2/20 0.46
▸ BCL2 P10415 1/20 0.44
▸ MCL1 Q07820 1/20 0.44
▸ L3MBTL1 Q9Y468 2/20 0.42
▸ MAPK1 P28482 2/20 0.42
▸ LMNA P02545 1/20 0.42
▸ PLA2G1B P04054 1/20 0.42
▸ NFKB1 P19838 1/20 0.42
▸ CASP3 P42574 1/20 0.42
▸ NFKB2 Q00653 1/20 0.42
▸ RELA Q04206 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL28857884 0.89 TTR (0.49) ALDH1A1NPC1RAB9ASMN1; SMN2MEN1
SCHEMBL16300502 0.83 PTPRC (0.46) ALDH1A1NPC1RAB9ASMN1; SMN2MEN1
SCHEMBL19871338 0.82 TTR (0.40) ALDH1A1NPC1RAB9ASMN1; SMN2MEN1
SCHEMBL18253130 0.81 KEAP1 (0.44) ALDH1A1NPC1RAB9ASMN1; SMN2MEN1
SCHEMBL6721047 0.81 NPC1 (0.42) ALDH1A1NPC1RAB9ASMN1; SMN2MEN1
SCHEMBL18933807 0.81 ELANE (0.50) ALDH1A1NPC1RAB9ASMN1; SMN2MEN1
SCHEMBL6720988 0.80 NPC1 (0.41) ALDH1A1NPC1RAB9ASMN1; SMN2MEN1
SCHEMBL188872 0.80 ELANE (0.57) ALDH1A1NPC1RAB9ASMN1; SMN2MEN1
SCHEMBL18412611 0.79 FAAH (0.45) ALDH1A1NPC1RAB9ASMN1; SMN2MEN1
SCHEMBL12269081 0.79 ALDH1A1 (0.53) ALDH1A1NPC1RAB9ASMN1; SMN2MEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-113226377-B Antibody drug conjugates comprising an eltrinastine derivative 法马马有限公司 2022-10-18 — — CN disclosed
Send feedback